$ARTL

$2.20 +$0.00 (0.0%) Close

$ARTL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.6M shares outstanding

Who owns ARTL?

By type of holder

Institutions 2.6% Everyone else 97.5%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 2.9%

Jane Street Group, LLC 1.4% · Farb Daniel Stuart 0.4%

Institutional ownership

2.6%

+1.5 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

+70.6K

by institutions in Q2 2026

New / sold out

5 / 6

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jane Street Group, LLC +53.3K
Geode Capital Management, LLC NEW +13.9K

Biggest sellers in Q2 2026

Kathmere Capital Management, LLC SOLD OUT −13.3K
Citigroup Inc SOLD OUT −3.1K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Artelo Biosciences, Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

−30.6%

−16.67% a year

Each share's claim on the business

+44.0%

grew without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.98M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

113.2%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting ARTL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
JS Jane Street Group, LLC	66.3K	1.44%	+53.3K (+407.2%)	Q1 '26	0.0%
Shares held by quarter Peak holding66.3K (Q2'26) Change over 8 quarters+66.3K Share of the company1.440% Jane Street Group, LLC's full portfolio →
GC Geode Capital Management, LLC	13.9K	0.30%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding16.0K (Q2'25) Change over 8 quarters+13.9K Share of the company0.300% Geode Capital Management, LLC's full portfolio →

Jane Street Group, LLC

66.3K

% of company

1.44%

Change vs last qtr

+53.3K (+407.2%)

Held since

Q1 '26

Geode Capital Management, LLC

13.9K

% of company

0.30%

Change vs last qtr

NEW

Held since

Q2 '26

13 more super investors behind a free account

See every manager holding Artelo Biosciences, Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ARTL on Form N-PORT; together they hold 0.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$11.3K	10.1K	0.22%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$8.93K	6.4K	0.14%	0.00%	May 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$11.3K

% of company

0.22%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$8.93K

% of company

0.14%

% of the fund

0.00%

As of

May 31, 2026

2 more funds behind a free account

See every fund holding Artelo Biosciences, Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
FD Farb Daniel Stuart 5%+ holder 13D · 0.8%	16.4K	0.36%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company0.360% Disclosed stake13D · 0.8% View the 13D/G filing →

Farb Daniel Stuart

5%+ holder13D · 0.8%

16.4K

% of company

0.36%

Change vs last qtr

—

Held since

—

Comments